BPI-9016M |
| Catalog No.GC65966 |
BPI-9016M is a potent, orally active, and selective dual c-Met and AXL tyrosine kinases inhibitor. BPI-9016M suppresses tumor cell growth, migration and invasion of lung adenocarcinoma.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1528546-94-2
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
BPI-9016M is a potent, orally active, and selective dual c-Met and AXL tyrosine kinases inhibitor. BPI-9016M suppresses tumor cell growth, migration and invasion of lung adenocarcinoma[1][2].
BPI-9016M (6.3-25 μM; 2 weeks) inhibited cell proliferation[2].
BPI-9016M (12.5-50 μM; 24 hpurs) induces accumulation of more tumor cells in the G1 phase[2].
BPI-9016M (3.1-50 μM) reduces expression of c-Met, p-c-Met, p-AKT and p-ERK in the H1299 and A549 cells in a dose-dependent manner[2].
The IC50 of BPI-9016M in several lung adenocarcinoma cell lines ( A549, H1299, H1650, H1975, HCC827, and PC-9 cells) as well as in primary lung adenocarcinoma cells are ranged from 5.3 μM to 27.1 μM[2].
Cell Proliferation Assay[2]
| Cell Line: | A549 and H1299 cells |
| Concentration: | 6.3, 12.5, 25 μM |
| Incubation Time: | 2 weeks |
| Result: | Colony formation was significantly inhibited in a dose-dependent manner. |
Cell Cycle Analysis[2]
| Cell Line: | A549 and H1299 cells |
| Concentration: | 12.5, 25, 50 μM |
| Incubation Time: | 24 hours |
| Result: | Induced accumulation of more tumor cells in the G1 phase. |
BPI-9016M (60 mg/kg; p.o.; daily for 16 or 12 days) dramatically restrains tumor growth in PDX xenografts in NOD/SCID mice[2].
| Animal Model: | NOD/SCID mice[2] |
| Dosage: | 60 mg/kg |
| Administration: | p.o.; daily for 16 or 12 days |
| Result: | Dramatically restrained tumor growth in PDX xenografts in NOD/SCID mice. |
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *